The week in health tech, explained in plain English.Get the free newsletter →
August 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Gilead and Merck Split Trial Results in Busy Biotech Week

By Healthcare Technology News ·

Two of the largest names in drug development, Gilead and Merck, delivered a split verdict on their pipelines this week, with one clinical trial succeeding and another failing, according to STAT News. The mixed outcomes underscore how unpredictable late-stage testing remains even for well-capitalized incumbents, where a single readout can move billions in market value.

The results landed amid a heavy stretch of industry activity. STAT News reported that AstraZeneca is pushing forward with a GLP-1 pill, positioning it to compete in the oral weight-loss market that has become the most contested arena in pharma. GSK, meanwhile, agreed to acquire a cancer startup for $10.6 billion, signaling that big pharma continues to buy its way into oncology pipelines rather than build them in-house.

For investors and operators, the through-line is clear: large drugmakers are placing concentrated bets on obesity and cancer, the two categories with the biggest commercial upside, while accepting that individual trials will still produce both wins and flops.

Sources

More in Finance

Finance

CMS Finalizes 2.3% FY2027 Pay Bumps for Rehab, Hospices

CMS finalized fiscal 2027 payment rules giving inpatient rehabilitation facilities and hospices each a 2.3% payment increase.

Why it matters: Thin Medicare increases set the revenue baseline for rehab and hospice operators already squeezed by labor and supply costs.

Finance

Crystalys Raises $130M for Gout Drug Dotinurad

Crystalys Therapeutics raised $130 million to advance its URAT1 inhibitor dotinurad through pivotal gout trials.

Why it matters: Fresh capital and a $950M Sobi deal show pharma is finally targeting gout, a common condition with few effective treatment options.

Finance

Hospital Margins Slip 5% as Profitability Divide Widens

Hospital operating margins fell 5% nationally in early 2026, deepening a profitability divide between smaller hospitals and large nonprofit systems.

Why it matters: A widening margin gap determines which hospitals can invest, consolidate, or survive, reshaping access and competition across the industry.